Pfizer Is Testing a Single-Pill Cure That Could Be a Game-Changer for the Coronavirus Pandemic

According to the British newspaper The Telegraph, this is a “remarkable experiment” that would be conducted by Pfizer and would involve about sixty volunteers in good health and between the ages of 18 and 60. The clinical trials of a single-pill anti-Covid 19 treatment could be completed by the end of the year.Pfizer Logo

“The molecule tested is a custom-made antivirus code-named PF 07321332,” the British newspaper said, adding that it was “classified as a protease inhibitor” and “formulated to attack the ‘backbone’ of the SARS-CoV-2 virus and prevent it from replicating in our noses, throats, and lungs. These are the same protease inhibitors that have pushed back the spread of HIV in the UK and around the world, it is further explained, which is why the researchers are hoping for a similar breakthrough to break the pandemic.

Read Also: Why Do Women Have Stronger Reactions to COVID-19 Vaccines?

“We designed PF-07321332 as a potential oral therapy that could be prescribed at the first sign of infection without requiring patients to go to the hospital or intensive care unit,” Mikael Dolsten, Pfizer’s chief scientific officer and president of global research, development, and medicine, said in an official statement released last month.

Pfizer’s pill has demonstrated “potent in vitro antiviral activity against SARS-CoV-2” as well as activity against other coronaviruses, raising the prospects for pandemic control. PF-07321332 is administered in combination with low doses of ritonavir, an antiviral used to treat HIV. In this way, it acts as a “booster” to increase the amount of PF-07321332 in participants’ blood.

Read Also: COVID-19: The Moderna Vaccine Still Offers Some Protection Against All Current Variants

The study drug was previously tested for safety in animals, and no side effects were noted. The initial human trials, which have now begun, are divided into three phases lasting a total of 145 days, with an additional 28 days for screening and dosing, reveals The Telegraph, which has access to documents handed out to trial participants.


Revealed: How a single pill home cure for Covid could be available this year

Related articles:

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines

Astrazeneca Vaccine: Could EDTA a Vaccine Preservative Be the Cause of Thrombosis?

Is the COVID-19 Pandemic Already Over? And Are We Now Dealing With COVID-20 and COVID-21 Instead?

New Study Shows That the English Variant Is More Deadly Than Previous Strains

Is the Russian COVID-19 Vaccine Really More Effective Than Pfizer’s?

Study Shows That Even When Vaccinated People Can Still Get Infected with the Coronavirus

Having Natural Immunity to the Original Coronavirus May Not Protect Against the South African and Brazilian Variants




Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.